98%
921
2 minutes
20
Background: Patient-reported outcome measure scores must be interpretable to be effective in a clinical setting. In this retrospective cohort study, we sought to establish the minimum clinically important difference (MCID) and patient acceptable symptom state (PASS) for health-related quality of life in Crohn's disease and to apply these thresholds to patients undergoing Crohn's-related bowel resection.
Methods: Eligible participants were adults with Crohn's disease completing a patient-reported outcome measure and an additional anchor question about digestive satisfaction or change from a prior clinical visit. Multiple questionnaires were evaluated for alignment with digestive satisfaction, and the best-performing short inflammatory bowel disease questionnaire (sIBDQ) was retained for further analysis. Clinically meaningful threshold ranges were established for the sIBDQ through anchor- and distribution-based methodologies. These thresholds were applied to patients undergoing Crohn's-related bowel resection in three areas: rates of target score achievement at postoperative time points, factors associated with sIBDQ scores at final follow-up, and accessibility in the electronic medical record.
Results: There were 492 and 228 responses included in the PASS and MCID analyses, respectively. For the sIBDQ, the PASS ranged from 51 to 63, while the MCID ranged from 6.5 to 9.5. In the 215 patients undergoing Crohn's-related bowel resection, the preoperative sIBDQ median (IQR) was 49 (30, 69) compared to postoperative scores of 56 (40, 73) at 1-12 months, 56 (39, 73) at 13-24 months, and 58 (42, 73) at more than 24 months. The PASS was achieved in 179 (84%) patients for at least one postoperative time point. Preoperative sIBDQ score and male sex were associated with higher quality of life at final follow-up.
Conclusion: In Crohn's disease, clinically meaningful targets for quality of life may complement traditional metrics when monitoring progress after operative intervention.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12408668 | PMC |
http://dx.doi.org/10.1007/s00464-025-11983-z | DOI Listing |
Asian J Endosc Surg
September 2025
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Introduction: Crohn's disease (CD) often leads to complex anorectal complications, posing significant challenges in surgical management. Transperineal abdominoperineal resection (TpAPR) has emerged as a minimally invasive alternative to APR. This study aims to evaluate the safety and efficacy of TpAPR compared to APR in patients with CD.
View Article and Find Full Text PDFJ Ethnopharmacol
September 2025
State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; Jiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center, Na
Ethnopharmacological Relevance: The traditional Chinese medicine Psoralea corylifolia L. (PCL) has been clinically used to treat diarrhea and gastrointestinal inflammatory disorders. G protein-coupled receptor 84 (GPR84) is emerging as a potential target for inflammatory bowel disease (IBD).
View Article and Find Full Text PDFInt Immunopharmacol
September 2025
Interdisciplinary eye research institute (EYE-X Institute), Bengbu Medical University, Bengbu, Anhui, China; Anhui Provincial Key Laboratory of Immunology in Chronic Diseases, Bengbu Medical University, Anhui, China. Electronic address:
Crohn's disease (CD) is a chronic inflammatory bowel condition that significantly impairs patients' quality of life. With no cure currently available, the need to discover novel biomarkers and develop effective therapeutic strategies is paramount. This study used a comprehensive machine learning approach to identify key predictive genes for CD, including S100A8, IGFBP5, CTSK, and S100P.
View Article and Find Full Text PDFEur J Gastroenterol Hepatol
September 2025
Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, The University of Jordan, Jordan University Hospital.
Aim: The purpose of our study was to evaluate the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its associated risk factors in patients with inflammatory bowel disease (IBD).
Methods: This was a retrospective chart review of patients who underwent treatment for IBD at Jordan University Hospital between January 2013 and 2022. Case finding methods and clinical chart reviews were used to evaluate the clinical profile of patients with IBD.
Eur J Gastroenterol Hepatol
September 2025
Department of Gastroenterology, First Affiliated Hospital of Shantou University Medical College, Shantou.
Background: Crohn's disease (CD) and rheumatoid arthritis (RA) are autoimmune diseases. CD is known to be closely associated with RA. However, the mechanisms underlying these relationships remain unclear.
View Article and Find Full Text PDF